USE OF TISSUE-PLASMINOGEN ACTIVATOR FOR REOPENING OF CLOTTED DIALYSIS CATHETERS

被引:38
|
作者
PAULSEN, D
REISAETHER, A
AASEN, M
FAUCHALD, P
机构
[1] Medical Department B, National Hospital of Norway, N-0027 Oslo-1
来源
NEPHRON | 1993年 / 64卷 / 03期
关键词
HEMODIALYSIS; CENTRAL VENOUS CATHETERS; FIBRINOLYTIC AGENTS; TISSUE PLASMINOGEN ACTIVATOR;
D O I
10.1159/000187374
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
The use of central venous catheters as permanent vascular access in chronic hemodialysis is complicated by clotting. We have tried a nonallergenic thrombolytic agent, tissue plasminogen activator (t-PA), to dissolve catheter luminal thrombosis. Eight patients, 7 in chronic hemodialysis and 1 treated by immune adsorption had 18 treatments with locally applied t-PA (2 mg/2 cm3). Fifteen out of 16 treatments with longer bolus dwell than 60 min were successful. No side effects occurred. t-PA dissolves clot formation efficiently and safely, the drug is nonallergenic and can therefore be given repeatedly.
引用
收藏
页码:468 / 470
页数:3
相关论文
共 50 条
  • [11] STABILITY OF RECOMBINANT TISSUE-PLASMINOGEN ACTIVATOR
    KO, PC
    WAGNER, DG
    CUPPLES, HP
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1994, 35 (04) : 2217 - 2217
  • [12] Tissue plasminogen activator can effectively declot peritoneal dialysis catheters
    Sahani, MM
    Mukhtar, KN
    Boorgu, R
    Leehey, DJ
    Popli, S
    Ing, TS
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2000, 36 (03) : 675 - 675
  • [13] NONFIBRINOGEN RELATED SPECIFICITY OF TISSUE-PLASMINOGEN ACTIVATOR FOR PLASMINOGEN
    COREY, DR
    MADISON, EL
    COOMBS, G
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1994, : 152 - 152
  • [14] BRADYKININ INCREASES TISSUE-PLASMINOGEN ACTIVATOR IN HUMANS
    BROWN, NJ
    NADEAU, J
    VAUGHAN, DE
    CIRCULATION, 1995, 92 (08) : 169 - 169
  • [15] COST-EFFECTIVENESS OF TISSUE-PLASMINOGEN ACTIVATOR
    LEE, TH
    NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (21): : 1443 - 1444
  • [16] Tissue-plasminogen activator for acute ischaemic stroke
    Ellis, SJ
    LANCET, 1997, 349 (9050): : 504 - 504
  • [17] FIBRINOLYTIC THERAPY USING TISSUE-PLASMINOGEN ACTIVATOR
    VANDER, JF
    CURRENT OPINION IN OPHTHALMOLOGY, 1993, 4 (03) : 56 - 61
  • [18] PHYSICAL CHARACTERIZATION OF RECOMBINANT TISSUE-PLASMINOGEN ACTIVATOR
    MARGOSSIAN, SS
    SLAYTER, HS
    KACZMAREK, E
    MCDONAGH, J
    BIOCHIMICA ET BIOPHYSICA ACTA, 1993, 1163 (03) : 250 - 256
  • [19] Use of recombinant tissue-plasminogen activator for aortic thrombolysis in a hypoproteinemic dog
    Clare, AC
    Kraje, BJ
    JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION, 1998, 212 (04) : 539 - +
  • [20] TISSUE-PLASMINOGEN ACTIVATOR (T-PA)
    MADHANI, J
    MOVSOWITZ, H
    KOTLER, MN
    THERAPEUTIC DRUG MONITORING, 1993, 15 (06) : 546 - 551